Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Hello Dose Expands Patient Education with No-Cost Webinars on GLP-1s, Longevity, Hormone Health and Peptide Therapy

Hello Dose.

News provided by

Hello Dose.

Sep 23, 2026, 09:02 ET

Share this article

Share toX

Share this article

Share toX

Founder Bracha Banayan, FNP, draws on her clinical experience and personal journey with GLP-1 therapy to help people better understand metabolic health, medical weight management and emerging wellness treatments

BROOKLYN, N.Y., Sept. 23, 2026 /PRNewswire/ -- Hello Dose, a clinician-led telehealth medical weight management practice offering services to eligible patients nationwide, is expanding its commitment to patient education through a series of no-cost webinars addressing some of today's most discussed health and wellness topics, including GLP-1 medications, metabolic health, longevity, hormone replacement therapy and peptide therapy.

Continue Reading
Hello Dose.
Hello Dose.

Led by Hello Dose founder Bracha Banayan, FNP, the webinars are held on select Monday evenings and are no-cost and open to the public. Upcoming dates and registration information are available at liinks.co/bracha_banayan.

For Banayan, the conversation surrounding GLP-1 medications is both professional and personal.

After gaining approximately 20 pounds during the COVID-19 pandemic, Banayan struggled to lose the weight despite focusing on diet and exercise. Initially skeptical of GLP-1 medications, she eventually decided to try semaglutide under appropriate medical care.

The experience changed her perspective and led her to look more closely at the relationship among weight, glucose regulation, insulin, nutrition, muscle, exercise and long-term metabolic health.

"I originally viewed GLP-1 medications primarily as weight-loss drugs, and I was skeptical," said Banayan. "My own experience made me look much more closely at the science of metabolic health and the relationship among weight, glucose regulation, insulin, inflammation, muscle, nutrition and long-term health. There is a much bigger conversation here than simply losing weight."

That broader conversation is now at the center of the Hello Dose educational webinar series.

Moving the GLP-1 Conversation Beyond Weight Loss

GLP-1 receptor agonists have become widely recognized for their role in diabetes treatment and medical weight management. Growing research and clinical interest have also expanded the conversation surrounding this class of medications and broader aspects of metabolic and cardiovascular health.

Banayan believes the increased attention surrounding GLP-1 medications makes accurate patient education particularly important.

During the webinars, she discusses GLP-1 therapy within the broader context of metabolic health rather than presenting medication as a substitute for nutrition, exercise and other healthy behaviors.

Topics include glucose and insulin regulation, food choices, maintaining and building muscle, physical activity, sleep and stress management. Participants also learn why long-term health involves more than simply reaching a target weight.

"Medication can be one tool, but it isn't the entire answer," Banayan said. "Nutrition matters. Muscle matters. Movement matters. Sleep and stress matter. The goal of these webinars is to help people understand how these pieces fit together and why sustainable health requires looking beyond the number on the scale."

Exploring Longevity Through a Broader Health Perspective

Longevity has become an increasingly prominent topic in health and wellness, but Banayan cautions against reducing it to a single medication, supplement or treatment.

Instead, the Hello Dose webinars examine factors that can influence metabolic and overall health, including maintaining muscle mass, regular physical activity, nutrition, sleep, stress management and appropriate medical care.

The educational sessions also explore topics surrounding hormone replacement therapy and peptide therapy, including what is currently known, areas where research continues to evolve, and why treatment decisions should be individualized and made with qualified healthcare providers.

"There is an enormous amount of information available to people right now, and not all of it is accurate or put into the proper context," Banayan said. "Education gives people the ability to ask better questions, understand potential risks and benefits, and have more informed conversations with their healthcare providers."

No-Cost Educational Webinars Open to the Public

Hello Dose's webinars address subjects including GLP-1 medications and medical weight management, metabolic health and glucose regulation, nutrition, maintaining muscle during weight loss and healthy aging, exercise and movement, hormone health, peptide therapy, sleep, stress management and longevity.

The webinars are no-cost and open to anyone, including individuals who are not currently Hello Dose patients.

Sessions are held on select Monday evenings, with upcoming webinar dates, topics and registration information available at liinks.co/bracha_banayan.

The webinars are intended for educational purposes and do not replace individualized medical advice, diagnosis or treatment. Prescription medications and other medical therapies should only be considered following an appropriate medical evaluation and based on each patient's medical history, needs and goals.

"These are conversations I wish more people were having before they make decisions about their health," Banayan said. "My goal isn't to convince everyone that they need a particular medication or treatment. It's to give people better information so they can make better decisions."

About Hello Dose

Hello Dose is a clinician-led telehealth medical weight management practice founded by Bracha Banayan, FNP. The practice offers personalized, medically supervised programs that may incorporate GLP-1 therapy, clinical monitoring, behavioral and lifestyle guidance, and ongoing patient education based on individual needs and clinical appropriateness.

Hello Dose's approach combines medical oversight with personalized support designed to help patients better understand their treatment, behaviors and metabolic health. Hello Dose offers telehealth services to eligible patients nationwide, subject to provider availability and applicable state regulations.

For more information about Hello Dose, visit HelloDose.com. For upcoming webinar dates and registration information, visit liinks.co/bracha_banayan.

Media Contact:
Bracha Banayan, FNP
Hello Dose
(607) 638-3948
HelloDose.com

SOURCE Hello Dose.

21%

more press release views with 
Request a Demo

Modal title

Also from this source

New York Healthcare Entrepreneur Bracha Banayan Launches Hello Dose Telehealth Platform for Clinician-Supervised GLP-1 Weight Management Care, Introducing the DROP™ Method Framework

New York Healthcare Entrepreneur Bracha Banayan Launches Hello Dose Telehealth Platform for Clinician-Supervised GLP-1 Weight Management Care, Introducing the DROP™ Method Framework

Bracha Banayan, FNP, founder of Hello Dose and IVDrips, has launched Hello Dose, a telehealth platform offering clinician-supervised GLP-1 medication ...

More Releases From This Source

Explore

Fitness/Wellness

Fitness/Wellness

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.